Boulevard Bio dreams big in immunology with $65M, sights on Vera’s IgAN drugnews2026-08-12T10:30:11+00:00August 12th, 2026|Endpoints News|
Ex-Legend chief Ying Huang becomes CEO of K2, eyes $250M Series Anews2026-08-11T12:00:44+00:00August 11th, 2026|Endpoints News|
Vaderis gets $152M to run Phase 3 of rare bleeding disorder treatmentnews2026-08-11T11:00:15+00:00August 11th, 2026|Endpoints News|
BioNTech vets get $25M seed funding for virtual cancer surveillance startupnews2026-08-10T11:00:22+00:00August 10th, 2026|Endpoints News|
Greg Verdine’s LifeMine raises $263M for safer immunosuppressantnews2026-08-06T10:30:08+00:00August 6th, 2026|Endpoints News|
Expedition gets another $115M for its twist on China NewCo modelnews2026-08-05T12:00:01+00:00August 5th, 2026|Endpoints News|
Dash Bio raises $30M Series A led by Oak HC/FTnews2026-08-03T11:00:07+00:00August 3rd, 2026|Endpoints News|
Claris collects $118M to take eye drop into pivotal testing next yearnews2026-07-28T12:00:02+00:00July 28th, 2026|Endpoints News|
Crystalys gets $130M to take Sobi-rivaling gout drug to marketnews2026-07-22T12:00:36+00:00July 22nd, 2026|Endpoints News|
UK biotech VC funding rebounds and reaches record highnews2026-07-20T11:23:41+00:00July 20th, 2026|Endpoints News|
